Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Penile Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

Docetaxel 5pembrolizumab 4Radiotherapy 3ulixertinib 2Trastuzumab 2Paclitaxel 2Nivolumab 2Magnetic Resonance Spectroscopy 2Erlotinib Hydrochloride 2Carboplatin 2Capecitabine 2trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sapanisertib 1sacituzumab govitecan 1relatlimab 1regorafenib 1pertuzumab 1palbociclib 1osimertinib 1oncogene protein E7, Human papillomavirus type 16 1omipalisib 1oblimersen 1motexafin gadolinium 1larotrectinib 1ipatasertib 1fludarabine 1erdafitinib 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × oncogene protein E7, Human papillomavirus type 16 × CNS × Clear all
NCT00019110 2015-04-29

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

National Cancer Institute (NCI)

Phase 1 Completed
CNSGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Salivary Gland Neoplasms, Vulvar Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡